Amwell® Announces Results for the Third Quarter 2026
Key Highlights
- ➤Q3 revenue $49.0 million exceeded previously provided guidance
- ➤2026 revenue outlook raised to $204 million-$206 million
- ➤2026 adjusted EBITDA outlook raised to negative $8 million-$7 million
- ➤Q4 adjusted EBITDA forecast at $0 million-$1 million
- ➤Positive operating cash flow objective reaffirmed for Q4 2026
Expert Statements
Dr. Ido Schoenberg, Chairman and CEO of Amwell
“Health plans and employers want engagement, outcomes and proof, and Amwell’s single platform is built to deliver all three.”
Dr. Ido Schoenberg, Chairman and CEO of Amwell
“Across six focus areas that all run on one platform, we are activating more members, simplifying their experience and deepening their relationship with clinicians, giving customers choice without the sprawl, demonstrating outcomes, and using a common data structure to show what works.”
Dr. Ido Schoenberg, Chairman and CEO of Amwell
“We expect to generate positive cash flow from operations in the fourth quarter, and we believe we are well positioned to be the trusted platform where AI-powered care runs.”
BOSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the third quarter ended September 30, 2026.
“Health plans and employers want engagement, outcomes and proof, and Amwell’s single platform is built to deliver all three,” said Dr. Ido Schoenberg, Chairman and CEO of Amwell. “Across six focus areas that all run on one platform, we are activating more members, simplifying their experience and deepening their relationship with clinicians, giving customers choice without the sprawl, demonstrating outcomes, and using a common data structure to show what works. We expect to generate positive cash flow from operations in the fourth quarter, and we believe we are well positioned to be the trusted platform where AI-powered care runs.”
Get started
Create a free account to read the full story.